ArticleFrontiers in oncology2022

A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors.

Nagla Abdel Karim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.